Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05764954 · ClinicalTrials.gov registry record · Phase 1
A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
A Phase 1 study of Adenocarcinoma of Lung, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 7
- Study locations
NCT05764954: Recruiting Phase 1 study of Adenocarcinoma of Lung, sponsored by Memorial Sloan Kettering Cancer Center.
NCT05764954 is a Phase 1 study of Adenocarcinoma of Lung that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 25 participants, below the 168-participant average among 5 other Adenocarcinoma of Lung trials with a reported enrollment target (85% lower). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05764954, a Phase 1 study of Adenocarcinoma of Lung, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 7
- Study locations
Study Summary
The researchers are doing this study to find out if treatment with TTFields using the NovoTTF-200T System is safe and practical (feasible) before surgical removal (resection) of lung adenocarcinoma (ADC). The researchers will also look at how the treatment may help the body's immune system to fight cancer.
Primary Outcome
based on Common Terminology Criteria for Adverse Events (CTCAE) version 5.0
Conditions Studied
Interventions
- DEVICE NovoTTF-200T System
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk - Commack (Consent Only) - Commack
- Memorial Sloan Kettering Westchester (Consent Only) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Consent Only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent Only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent Only) - Middletown
- Memorial Sloan Kettering Bergen (Consent Only) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-08-04 |
| Est. Completion | 2027-08 |
| Phase | Phase 1 |
What NCT05764954 shows while recruiting
NCT05764954 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 168-participant average among 5 other Adenocarcinoma of Lung trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Adenocarcinoma of Lung appearing as the primary indexed condition, and to 1 intervention - of which NovoTTF-200T System is the first listed.
NCT05764954 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT05764954 about?
NCT05764954 is a clinical study titled "A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma". The researchers are doing this study to find out if treatment with TTFields using the NovoTTF-200T System is safe and practical (feasible) before surgical removal (resection) of lung adenocarcinoma (ADC). The researchers will also look at how the treatment may help the body's immune system to fight ...
What is the current status of trial NCT05764954?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2023-08-04. Estimated completion is 2027-08.
What conditions does trial NCT05764954 study?
This clinical trial studies the following conditions: Adenocarcinoma of Lung.
What interventions are being tested in trial NCT05764954?
The interventions under investigation include: NovoTTF-200T System (DEVICE).
Who is sponsoring clinical trial NCT05764954?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05764954 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adenocarcinoma of Lung
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
COMPLETED · Phase 1
-
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
RECRUITING · Phase 2
-
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
RECRUITING
-
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
RECRUITING · Phase 2
-
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
ACTIVE NOT RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI